Pharmaceuticals, Biotechnology and Life Sciences
New data to be presented on the effect of Nubeqa® (darolutamide) on cerebral blood flow in men with non-metastatic castration-resistant…
–2019 revenue of $428 million, driven primarily by U.S. LINZESS® (linaclotide) collaboration revenue– –GAAP net income from continuing operations of…
– Can-Fite successfully concluded its End-of-Phase II meeting with the U.S. FDA recently – One Phase III trial for concurrent…
U.S. FDA set a target action date of August 17, 2020 Application based on results from the TRANSCEND NHL 001…
BOCA RATON, Fla. & CHARLESTON, S.C.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, and Afaxys Pharma, LLC, a…
Data shows that Calidi’s cell-based platform protects and potentiates oncolytic vaccinia virus resulting in enhanced oncolytic virotherapy SAN DIEGO–(BUSINESS WIRE)–#bio—Calidi…
The Connect™ Auto-Sensing Injection System honored at Pharmapack Europe MENLO PARK, Calif.–(BUSINESS WIRE)–Credence MedSystems, an innovator in injectable drug delivery…
— SCRUM-Japan aims to apply blood-based genomic insights to inform and accelerate the development of precision medicine approaches for patients…
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its financial results for the…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF) today announced that it has entered into agreements with First…